# Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

Article · Javed Butler, Sanjiv Jayendra Shah, Mark Colquhoun Petrie, Barry A. Borlaug, Steen Zabell Abildstrom, Melanie Jane Davies, G. Kees Hovingh, Dalane W. Kitzman, Daniél V. Møller, Subodh Verma, Mette Nygaard Einfeldt, Marie L.S. Lindegaard, Søren Rasmussen, Walter P. Abhayaratna, Fozia Zahir Ahmed, Tuvia Ben Gal, Vijay Chopra, Justin Adrian Ezekowitz, Michael L.X. Fu, Hiroshi Ito, Małgorzata Lelonek, Vojtěch Melenovský, Béla Péter Merkely, Julio E. Núñez, Eduardo Roque Perna and 7 more

- Archive id: doi:10.1016/s0140-6736(24)00469-0
- Published: 2024-04-01
- Venue: The Lancet
- DOI: https://doi.org/10.1016/s0140-6736(24)00469-0
- PMID: 38599221
- Citations: 384
- Source URL: https://doi.org/10.1016/s0140-6736(24)00469-0
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [GLP-1 & Incretin Therapies](https://space-kitty.com/topics/glp1-metabolic)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.